<p>This study investigated fragmentation patterns in urine and plasma cell-free DNA and evaluated the relevance of such analysis for cancer diagnostics using urine samples. Specifically, we performed whole-genome sequencing at variable depths and evaluated genome-wide coverage in urine and plasma samples, relative to known genome annotation features. Tumor/germline exome sequencing data included was used to identify genome-wide copy number changes and their effect on cfDNA fragmentation in corresponding genomic regions in urine samples. Data included in this submission is whole-genome sequencing of urine and/or plasma cell-free DNA from healthy volunteers and/or cancer patients, and whole-exome sequencing of tumor DNA and germline DNA (peripheral blood cells) from cancer patients. </p>

Analysis of Recurrently Protected Genomic Regions in Urine Cell-Free DNA

Cell-Free Nucleic Acids study with WGS, WXS data on dbGaP (60 participants)

Analysis of Recurrently Protected Genomic Regions in Urine Cell-Free DNA

Description

Applying For Access

Summary